Lobbying Filing Details
Total Spending
$670,000
Activities
4
Lobbyists
2
Gov't Entities
8
Filing Information
- Filing UUID:
27ec18dc-ed22-4c5c-87fb-7179547d9e6b- Type:
- Q1 - 1st Quarter - Report
- Period:
- 2023 - 1st Quarter (Jan 1 - Mar 31)
- Date Posted:
- April 19, 2023 at 5:40 PM
- Income:
- $0
- Expenses:
- $670,000
- Expense Method:
- A
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: Samantha Ventimiglia
Registrant
VERTEX PHARMACEUTICALS INCORPORATED
Global biotechnology company
Boston, MassachusettsClient
VERTEX PHARMACEUTICALS INCORPORATED
Massachusetts, United States of AmericaLobbying Activities (4)
Activity 1
Budget/AppropriationsIssues related to funding for the Food and Drug Administration - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act; General education about policies to improve outcomes for patients with APOL-1 kidney disease.
Lobbyists (2)
- SAMANTHA VENTIMIGLIA
- MATTHEW O SCHUMAKER
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 2
Health IssuesGeneral education about federal policies impacting pharmaceutical development, approval, and reimbursement; Patient access to non-opioid pain medicines; Issues related to FDA drug approval process.
Lobbyists (2)
- SAMANTHA VENTIMIGLIA
- MATTHEW O SCHUMAKER
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 3
Medicare/MedicaidGeneral education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs. Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines.
Lobbyists (2)
- SAMANTHA VENTIMIGLIA
- MATTHEW O SCHUMAKER
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES
Activity 4
Taxation/Internal Revenue CodeIssues related to corporate and international tax policy and research and development tax credits.
Lobbyists (2)
- SAMANTHA VENTIMIGLIA
- MATTHEW O SCHUMAKER
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES